Macquarie University Hospital, Sydney, Australia.
Assam Medical College, Barbari, Dibrugarh, Assam, India.
Ortop Traumatol Rehabil. 2021 Jun 30;23(3):157-165. doi: 10.5604/01.3001.0014.9152.
Adhesive Capsulitis of shoulder (AdCS) is a treatment dilemma for surgeons. Intraarticular Corticosteroid Injection (IACI) has shown only short-term benefit in improving shoulder-related disability. Suprascapular nerve block (SSNB) has shown promise in trials in reducing chronic shoulder pain. Thus a RCT was conducted to compare the efficacy of SSNB versus IACI in the treatment of AdCS.
86 patients with AdCS were divided into SSNB and IACI groups by block randomization. SSNB group received single Suprascapular Nerve Block with 10ml of 0.5% Bupivacaine while IACI group received single injection of 40mg Triamcinolone and 1ml 2% Lignocaine in the shoulder; both followed by physiotherapy and followed-up and evaluated with SPADI and modified Constant scores at 1, 6 and 12 weeks.
Statistically significant improvements occurred in both groups. At 12 weeks, the SPADI and Con-stant score for SSNB improved to 9.62±10.07 and 36.95±3.43 respectively (p<0.001); and for IACI improved to 11.65±5.56 and 35.07±3.32 respectively (p <0.001). The difference in the scores between the 2 groups at 1st and 6th week was insignificant, but was statistically significant in favour of SSNB at 12 weeks (p=0.002).
肩粘连性囊炎(AdCS)是外科医生面临的治疗难题。关节内皮质类固醇注射(IACI)已显示出在改善与肩部相关的残疾方面仅具有短期益处。肩胛上神经阻滞(SSNB)在临床试验中已显示出减少慢性肩部疼痛的潜力。因此,进行了一项 RCT,以比较 SSNB 与 IACI 在治疗 AdCS 中的疗效。
将 86 例 AdCS 患者按块随机分为 SSNB 和 IACI 组。SSNB 组接受单次肩胛上神经阻滞,用 0.5%布比卡因 10ml;IACI 组在肩部接受单次注射 40mg 曲安奈德和 1ml 2%利多卡因;两组均接受物理治疗并随访,在 1、6 和 12 周时分别用 SPADI 和改良 Constant 评分进行评估。
两组均有显著改善。在 12 周时,SSNB 的 SPADI 和 Constant 评分分别改善至 9.62±10.07 和 36.95±3.43(p<0.001);IACI 分别改善至 11.65±5.56 和 35.07±3.32(p<0.001)。第 1 周和第 6 周两组评分差异无统计学意义,但第 12 周时 SSNB 有统计学意义(p=0.002)。